Baxter International (NYSE:BAX) and Dynatronics (NASDAQ:DYNT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations.
This is a breakdown of recent recommendations and price targets for Baxter International and Dynatronics, as reported by MarketBeat.com.
||Strong Buy Ratings
Baxter International presently has a consensus price target of $77.00, indicating a potential upside of 10.86%. Given Baxter International’s higher probable upside, equities analysts plainly believe Baxter International is more favorable than Dynatronics.
Baxter International pays an annual dividend of $0.76 per share and has a dividend yield of 1.1%. Dynatronics does not pay a dividend. Baxter International pays out 30.6% of its earnings in the form of a dividend.
This table compares Baxter International and Dynatronics’ net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Risk and Volatility
Baxter International has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of -0.15, suggesting that its share price is 115% less volatile than the S&P 500.
Valuation and Earnings
This table compares Baxter International and Dynatronics’ gross revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Baxter International has higher revenue and earnings than Dynatronics. Dynatronics is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
83.1% of Baxter International shares are held by institutional investors. Comparatively, 11.6% of Dynatronics shares are held by institutional investors. 0.1% of Baxter International shares are held by insiders. Comparatively, 51.8% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Baxter International beats Dynatronics on 12 of the 14 factors compared between the two stocks.
Baxter International Company Profile
Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Dynatronics Company Profile
Dynatronics Corporation designs, manufactures, distributes, and markets physical medicine products in the United States and internationally. It manufactures and sells electrotherapy, therapeutic ultrasound, phototherapy, thermal therapy, iontophoresis devices, and other modalities; traction therapy equipment; and medical supplies and soft goods, including hot and cold packs, lumbar rolls, exercise balls, wrist splints, ankle weights, cervical collars and pillows, slings, bolsters, positioning wedges, back cushions, weight racks, rehabilitation products, back and wrist braces. The company also sells mat platforms, and other rehabilitation and athletic training room products. In addition, it distributes additional exercise equipment, treatment tables, parallel bars, hand therapy products, hot and cold therapy products, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, walkers, treadmills, stair climbers, heating units for hot packs, whirlpools, electrodes, hydrotherapy and aquatic exercise products, clinical supplies, diagnostic and evaluation products, orthopedic supports, patient positioners, rehabilitation equipment, traction equipment, wound and edema care products, nutritional supplements, and portable electrotherapy products. The company sells its products to licensed practitioners, such as physical therapists, chiropractors, athletic trainers, professional sports teams and universities, sports medicine specialists, post-acute care facilities, hospitals and clinics through direct sales representatives and independent dealers, as well as through its e-commerce Websites and product catalogs. It also exports its products to approximately 30 countries. The company was founded in 1979 and is headquartered in Cottonwood Heights, Utah.
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.